Nortech Systems Inc
NSYSNortech Systems Inc. (NSYS) is a manufacturer of complex electronic and electro-mechanical components, providing engineering, design, and manufacturing services for a variety of industries including medical, aerospace, defense, industrial, and communications. The company specializes in custom cable assemblies, printed circuit board assemblies, and box-build systems, offering end-to-end solutions to meet clients' technical requirements.
Company News
Shares of FactSet Research Systems Inc. (NYSE: FDS) fell sharply during Thursday’s session after the company reported worse-than-expected second-quarter revenue and issued FY24 guidance. FactSet Research posted adjusted earnings of $4.22 per share, beating market estimates of $3.88 per share. The company’s quarterly sales came in at $545.95 ...
U.S. stocks were higher, with the Dow Jones index gaining around 250 points on Thursday. Shares of Guess?, Inc. (NYSE: GES) rose sharply during Thursday’s session as the company reported better-than-expected fourth-quarter financial results and declared a special dividend of $2.25 per share. Guess? reported quarterly earnings of $2.01 per shar...
Gainers Invitae Corporation (NYSE: NVTA) surged 278.5% to close at $8.63 after the company reported better-than-expected Q2 EPS. BioAtla, Inc. (NASDAQ: BCAB) jumped 83.1% to close at $6.61 on Wednesday following Q2 results. Allego N.V. (NYSE: ALLG) gained 57.1% to settle at $5.83 amid volatility in low-float former SPAC names. Lixiang Education ...
Gainers BioAtla, Inc. (NASDAQ: BCAB) gained 50.1% to $5.42 following Q2 results. Euro Tech Holdings Company Limited (NASDAQ: CLWT) surged 39.5% to $2.0380. Performance Shipping Inc. (NASDAQ: PSHG) gained 33% to $0.5418. The Trade Desk, Inc. (NASDAQ: TTD) climbed 32% to $71.93 after the company reported better-than-expected Q2 sales results and ...
Gainers Kaspien Holdings Inc. (NASDAQ: KSPN) shares climbed 161.9% to close at $6.81 on Monday on heavy volume amid mention of the stock on social media. Pliant Therapeutics, Inc. (NASDAQ: PLRX) shares surged 159% to close at $23.00 on Monday after the company said its treatment for Idiopathic Pulmonary Fibrosis was well tolerated in a Phase 2a...
